Literature DB >> 18614902

Hypoglycemia and strict glycemic control in critically ill patients.

Titia M Vriesendorp1, J Hans DeVries, Joost B L Hoekstra.   

Abstract

PURPOSE OF REVIEW: In contrast to patients with diabetes mellitus, data on consequences of hypoglycemia in critically ill patients are sparse. The purpose of this review is to summarize available data on prevalence of hypoglycemia, risk factors, and possible consequences of hypoglycemia in critically ill patients. RECENT
FINDINGS: There is strong evidence that strict glycemic control is beneficial for critically ill patients. Recent attempts to confirm these findings have not succeeded. Instead, they have increased the fear for negative consequences of hypoglycemia. Hypoglycemia is four to seven times more frequent in patients treated with strict glycemic control. Risk factors for hypoglycemia are a change in nutrition without adjustment of insulin treatment, diabetes mellitus, sepsis, shock, liver failure, and the need for renal replacement therapy. Consequences of hypoglycemia in critically ill patients are not well defined, but overall current evidence suggests that beneficial effects of strict glycemic control outweigh possible negative effects of hypoglycemia.
SUMMARY: Hypoglycemia should be avoided in critically ill patients, but not at the cost of less stringent glycemic control. Strict glycemic control with a low incidence of hypoglycemia can be achieved with a validated (computerized) algorithm and increased surveillance in patients with an increased risk for hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18614902     DOI: 10.1097/MCC.0b013e328306c7b1

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  7 in total

1.  Are tight glycemic targets achieved through intensive insulin infusion still applicable in the intensive care unit?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-01

Review 2.  A review of perioperative glucose control in the neurosurgical population.

Authors:  Joshua H Atkins; David S Smith
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

3.  Role of inhibitory κB kinase and c-Jun NH2-terminal kinase in the development of hepatic insulin resistance in critical illness diabetes.

Authors:  Shaoning Jiang; Joseph L Messina
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-06-16       Impact factor: 4.052

4.  Injury-induced insulin resistance in adipose tissue.

Authors:  Vanessa L Williams; Rachel E Martin; John L Franklin; Robert W Hardy; Joseph L Messina
Journal:  Biochem Biophys Res Commun       Date:  2012-04-13       Impact factor: 3.575

5.  Consecutive nursing shifts and the risk of hypoglycemia in critically ill patients who are receiving intravenous insulin: a multicenter study.

Authors:  Najib T Ayas; Andrew T Jeklin; Harriet Tholin; Ann E Rogers; Peter Dodek; A J Hirsh-Allen; Monica Norena; Hubert Wong
Journal:  J Clin Sleep Med       Date:  2020-06-15       Impact factor: 4.062

6.  On the management of hyperglycaemia in critically ill patients undergoing surgery.

Authors:  Iakovos Nomikos; Maria Kyriazi; Dimitra Vamvakopoulou; Andreas Sidiropoulos; Athanasios Apostolou; Aspasia Kyritsaka; Evangelos Athanassiou; Nikolaos C Vamvakopoulos
Journal:  J Clin Med Res       Date:  2012-07-20

Review 7.  Health technology assessment review: Computerized glucose regulation in the intensive care unit--how to create artificial control.

Authors:  Miriam Hoekstra; Mathijs Vogelzang; Evgeny Verbitskiy; Maarten W N Nijsten
Journal:  Crit Care       Date:  2009-10-16       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.